Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels

J Allergy Clin Immunol. 2007 Nov;120(5):1223-5. doi: 10.1016/j.jaci.2007.08.060. Epub 2007 Oct 22.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Allergic Agents / administration & dosage
  • Anti-Allergic Agents / pharmacology
  • Anti-Allergic Agents / therapeutic use*
  • Antibodies, Anti-Idiotypic / administration & dosage
  • Antibodies, Anti-Idiotypic / therapeutic use
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Dermatitis, Atopic / drug therapy*
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Immunoglobulin E / drug effects*
  • Immunoglobulin E / genetics
  • Male
  • Middle Aged
  • Omalizumab
  • Treatment Outcome

Substances

  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • anti-IgE antibodies
  • Omalizumab
  • Immunoglobulin E